腎臓損傷の調節における炎症関連の lncRNA;新しい lncRNA ベースの配送プラットフォームに重点を置く
Xu Fu1, Rawaa Najim Alkhamessi2, Raed Fanoukh Aboqader Al-Aouadi3
1Department of Nephrology, Central Hospital of Zibo, Zibo, 255000, Shandong, China.
Naunyn-Schmiedeberg's archives of pharmacology
|September 1, 2025
まとめ
長い非コーディングRNA (lncRNAs) は,炎症と細胞損傷を調節することによって,腎臓疾患において重要な役割を果たします. 腎臓疾患を標的とした lncRNA 療法のための新しい投与戦略が開発されています.
科学分野:
- 分子生物学
- 遺伝学
- 生物化学
背景:
- 長い非コーディングRNA (lncRNAs) は,多様な細胞機能を持つ遺伝子発現の重要なレギュレータである.
- 調節不良の lncRNA は様々な腎臓疾患の病原性に関与している.
- lncRNAsは炎症,線維症,腎臓の細胞死のようなプロセスを影響する.
研究 の 目的:
- 腎臓損傷における lncRNAsの分子メカニズムを見直す
- 腎臓疾患における lncRNA の治療の可能性を調査する.
- lncRNAベースの治療法の新しい投与戦略を要約する.
主な方法:
- 腎臓病理学における lncRNAsに関する最近の研究の文献レビュー.
- 炎症,線維症,細胞死における lncRNAの役割の分析
- lncRNA配送システム (LV,LNP,EV) の要約
主要な成果:
- lncRNAは腎臓とポドサイトの損傷,炎症,線維症,急性腎臓損傷から慢性腎臓疾患への移行に関与しています.
- lncRNAsは腎臓病の進行における重要な経路を調節する.
- LV,LNP,EVシステムは lncRNAの配送に好機を示しています.
結論:
- lncRNAは腎臓病の治療に 有望な標的となる.
- lncRNAメカニズムを理解することは 効果的な治療法の開発に不可欠です
- 先進的な投与システムは lncRNAベースの腎臓疾患治療に不可欠です.
関連する概念動画
02:39lncRNA - Long Non-coding RNAs
8.9K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.9K
01:29Acute Kidney Injury II: Pathophysiology
72
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
72
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
57
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
57
01:22Acute Kidney Injury I: Introduction
72
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
72
01:22Acute Kidney Injury VI: Nursing Management
57
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
57